GRAIL, LLC (GRAL)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $4.75B
Last updated: Nov 17, 2026 at 4:15 PM ET
GRAIL, LLC (GRAL) Statistics
GRAIL, LLC (GRAL) has a market cap of $4.75B and an enterprise value of $4.72B. It kept -243.80% of revenue as net income over the last 12 months. Its share count is up 29.49% from a year earlier.
Total Valuation
Enterprise value is 0.61% below the market cap, as cash exceeds debt.
| Market Cap | $4.75B |
|---|---|
| Enterprise Value | $4.72B |
| Latest price (Nov 17, 2026) | $105.88 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 29.7x and 2.0x.
| P/S Ratio | 29.7x |
|---|---|
| Forward P/S | 28.2x |
| P/B Ratio | 2.0x |
| P/TBV Ratio | 7.0x |
Price Statistics
The stock is up 32.97% over 52 weeks and trades 13.55% below its 50-day average.
| Beta (1Y) | 2.97 |
|---|---|
| 52-Week Change | +32.97% |
| 1-Month Change | -13.51% |
| 3-Month Change | +43.16% |
| 6-Month Change | +73.60% |
| Total Return (1Y) | +32.96% |
| Return vs SPY (1Y) | +18.42% |
| Max Drawdown (1Y) | -62.92% |
| Max Drawdown (3Y) | -62.92% |
| Sharpe Ratio (1Y) | 0.23 |
| Correlation with SPY (1Y) | 0.36 |
| 50-Day Average | $122.47 |
| 200-Day Average | $79.30 |
| 52-Week Range | $41.50 to $166.47 |
| RSI (14 Days) | 37.9 |
| Average Volume (20 Days) | 897.80K |
Financial Position
Current assets cover 8.93x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.93x |
|---|---|
| Quick Ratio | 8.74x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -16.55% and return on assets is -14.88% over the last 12 months.
| Return on Equity (ROE) | -16.55% |
|---|---|
| Return on Assets (ROA) | -14.88% |
| Asset Turnover | 0.06x |
| Inventory Turnover | 4.90x |
| Receivables Turnover | 8.60x |
| Cash Conversion Cycle | 81 days |
Scores
GRAL has an Altman Z-Score of 5.02, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.02 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $166.60M over the last 12 months is up 17.47% from the 12 months before.
| Revenue | $166.60M |
|---|---|
| Revenue Growth (YoY) | +17.47% |
| Gross Profit | $77.77M |
| Operating Income | -$578.58M |
| Pretax Income | -$548.07M |
| Net Income | -$406.18M |
| EBITDA | -$447.90M |
| Reported EPS (TTM) | -$8.58 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 89.74% of the $2.73B in total assets.
| Cash and Equivalents | $28.98M |
|---|---|
| Total Debt | $0 |
| Net Cash | $28.98M |
| Net Cash Per Share | $0.62 |
| Working Capital | $748.47M |
| Shareholder Equity | $2.45B |
| Book Value Per Share | $52.45 |
| Tangible Book Value | $706.71M |
| Tangible Book Per Share | $15.11 |
| Total Assets | $2.73B |
| Total Liabilities | $277.04M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $5.76M of capital spending, operating cash flow left -$312.00M of free cash flow.
| Operating Cash Flow | -$306.24M |
|---|---|
| Capital Expenditures | $5.76M |
| Free Cash Flow | -$312.00M |
| FCF Per Share | -$6.99 |
| Depreciation and Amortization | $131.19M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -347.28%.
| Gross Margin | 46.68% |
|---|---|
| Operating Margin | -347.28% |
| Pretax Margin | -328.97% |
| Net Margin | -243.80% |
| EBITDA Margin | -268.84% |
| FCF Margin | -187.27% |
Growth
Revenue grew 38.37% a year over 3 years.
| Revenue Growth (3Y CAGR) | +38.37% |
|---|---|
| Book Value Per Share Growth (2Y CAGR) | -26.58% |
| Tangible Book Per Share Growth (2Y CAGR) | +181.41% |
Dividends and Yields
GRAL does not pay a dividend. Its free cash flow yield is -6.30%.
| FCF Yield | -6.30% |
|---|---|
| Buyback Yield | -8.55% |
| Shareholder Yield | -8.55% |
Peer Position
Against 12 similar companies, GRAL has the highest P/S.
P/S RatioPeer median 3.9x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.43%
| P/S Ratio | 29.7x vs 3.9x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +17.47% vs +10.43% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GRAL
What is GRAL's market cap?
GRAIL, LLC has a market cap of $4.75B. Its enterprise value, which adds debt and subtracts cash, is $4.72B.
How many shares of GRAL are outstanding?
GRAIL, LLC has 46.78M shares outstanding. The count is up 29.49% from a year earlier.
Does GRAL pay a dividend?
No. GRAIL, LLC does not pay a dividend.
How much debt does GRAL have?
GRAIL, LLC has $0 of total debt and $28.98M of cash and equivalents, a net cash position of $28.98M.
GRAL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors